126 related articles for article (PubMed ID: 18845997)
1. Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
Jani AB; Johnstone PA; Liauw SL; Master VA; Brawley OW
Am J Clin Oncol; 2008 Aug; 31(4):375-8. PubMed ID: 18845997
[TBL] [Abstract][Full Text] [Related]
2. Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry.
Jani AB; Master VA; Rossi PJ; Liauw SL; Johnstone PA
Prostate Cancer Prostatic Dis; 2007; 10(4):347-51. PubMed ID: 17505529
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis.
Jani AB; Johnstone PA; Liauw SL; Master VA; Rossi PJ
Am J Clin Oncol; 2010 Apr; 33(2):168-72. PubMed ID: 19745696
[TBL] [Abstract][Full Text] [Related]
4. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
5. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
CMAJ; 2000 Apr; 162(7):977-83. PubMed ID: 10763395
[TBL] [Abstract][Full Text] [Related]
6. A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.
Terakedis BE; Rossi PJ; Liauw SL; Johnstone PA; Jani AB
Am J Clin Oncol; 2010 Dec; 33(6):619-23. PubMed ID: 20051808
[TBL] [Abstract][Full Text] [Related]
7. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry.
Stephenson RA; Smart CR; Mineau GP; James BC; Janerich DT; Dibble RL
Cancer; 1996 Apr; 77(7):1342-8. PubMed ID: 8608513
[TBL] [Abstract][Full Text] [Related]
8. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer.
Taylor SH; Merriman KW; Spiess PE; Pisters L
Cancer; 2006 Feb; 106(3):559-65. PubMed ID: 16369982
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
Patel S; Macdonald OK; Suntharalingam M
Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
[TBL] [Abstract][Full Text] [Related]
10. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001.
Choi M; Fuller CD; Thomas CR; Wang SJ
Gynecol Oncol; 2008 May; 109(2):203-9. PubMed ID: 18329082
[TBL] [Abstract][Full Text] [Related]
11. Applying population dynamics modeling to patients with lymph node positive prostate cancer.
Johnstone PA; Riffenburgh RH; Rossi PJ; Assikis V; Master VA; Jani AB
J Urol; 2007 Nov; 178(5):1952-5; discussion 1955-6. PubMed ID: 17868720
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
13. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.
Ryan CJ; Elkin EP; Small EJ; Duchane J; Carroll P
Urol Oncol; 2006; 24(5):396-402. PubMed ID: 16962488
[TBL] [Abstract][Full Text] [Related]
14. Trends in the incidence and treatment of parathyroid cancer in the United States.
Lee PK; Jarosek SL; Virnig BA; Evasovich M; Tuttle TM
Cancer; 2007 May; 109(9):1736-41. PubMed ID: 17372919
[TBL] [Abstract][Full Text] [Related]
15. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
Kim HM; Goodman M; Kim BI; Ward KC
J Registry Manag; 2011; 38(3):120-31. PubMed ID: 22223054
[TBL] [Abstract][Full Text] [Related]
16. Population-based study of islet cell carcinoma.
Yao JC; Eisner MP; Leary C; Dagohoy C; Phan A; Rashid A; Hassan M; Evans DB
Ann Surg Oncol; 2007 Dec; 14(12):3492-500. PubMed ID: 17896148
[TBL] [Abstract][Full Text] [Related]
17. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
[TBL] [Abstract][Full Text] [Related]
18. 5- and 10-year survival in cancer patients aged 90 and older: a study of 37,318 patients from SEER.
Saltzstein SL; Behling CA
J Surg Oncol; 2002 Nov; 81(3):113-6; dicussion 117. PubMed ID: 12407720
[TBL] [Abstract][Full Text] [Related]
19. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
Tonita JM; Skarsgard D; Muhajarine N
Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
[TBL] [Abstract][Full Text] [Related]
20. A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica.
Coard KC; Skeete DH
BJU Int; 2009 Jun; 103(11):1482-6. PubMed ID: 19076136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
